Minimum dataset for monitoring national human immunodeficiency virus pre-exposure prophylaxis (HIV PrEP) programmes: a five-nation consensus, 2019

Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP), the use of antiretroviral medication to prevent HIV acquisition, is a highly effective biomedical prevention tool. The World Health Organization (WHO) recommends PrEP for people at substantial risk of HIV infection, as part of combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saunders, John, Gill, O Noel, Delpech, Valerie, Estcourt, Claudia, Sullivan, Ann, Ogaz, Dana, Brown, Alison, Miltz, Ada, Aghaizu, Adamma, Chada, Naresh, Hurley, Caroline, Lyons, Fiona, Steedman, Nicola, Goldberg, David, Wallace, Lesley, McMaster, Duncan, Couzens, Zoe, Fina, Laia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193990/
https://www.ncbi.nlm.nih.gov/pubmed/34114539
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.23.2001595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193990/
https://www.ncbi.nlm.nih.gov/pubmed/34114539
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.23.2001595

Ejemplares similares